Wednesday, June 2, 2021

Investor Ideas Potcasts 571, Cannabis News and Stocks on the Move; (OTC: $ROSN), (TSXV: $HITI.V) (NASDAQ: $HITI), (TSX: $CWEB.TO) (OTCQX: $CWBHF), (NYSE: $HEXO) (TSX: $HEXO.TO)



Investor Ideas Potcasts 571, Cannabis News and Stocks on the Move; (OTC: $ROSN), (TSXV: $HITI.V) (NASDAQ: $HITI), (TSX: $CWEB.TO) (OTCQX: $CWBHF), (NYSE: $HEXO) (TSX: $HEXO.TO)


Delta, Kelowna, BC, June 2, 2021 ( Newswire), a global news source covering leading sectors including marijuana and hemp stocks and its potcast site,  release today’s podcast edition of  cannabis news and stocks to watch plus insight from thought leaders and experts.


Listen to the podcast:


Read this in full at


Hear Investor ideas cannabis potcast on iTunes  

Hear the investor ideas potcast on Spotify


Today’s podcast overview/transcript:


Good afternoon and welcome to another episode of "Potcast" featuring cannabis news, stocks to watch as well as insights from thought leaders and experts.


In today’s podcast we look at a few public company announcements.


ROSINBOMB (OTC:ROSN), industry leading developer and manufacturer of the highly acclaimed ROSINBOMB line of solventless extraction presses and Industry Icon Tommy Chong, recently announced their exclusive collaboration to offer consumers a custom Tommy-art skinned Rosinbomb Rocket.


In celebration of the launch, Tommy was a featured guest on’s Blunt Business Show which can be heard here.


During the interview Tommy expressed his excitement for this exclusive collaboration in which his personal artwork and handwritten signature adorn each Rosinbomb Tommy Chong Rocket, “This rosin press does everything people use to do manually.” He stated., “This rosin press eliminates all the heavy labor, work, time and everything else and you get the purest of the pure!” he added as reference to Rosinbomb’s mission of enabling consumers to craft pure solventless extract.


Rosinbomb’s CEO, Fred Angelopoulos said, “Tommy Chong stands among the very few true Industry and Cultural icons within our industry. He has touted the healing and wellness benefits of cannabis for almost 50 years and has been a leader in the industry.” Angelopoulos continued, “It has been our true pleasure and honor to have partnered with Tommy on this project and we look forward to future collaborations that celebrate Tommy, our products and the customers who appreciate us both.”


Ryan Mayer, Founder & President of Rosinbomb said, “Working with Tommy Chong is a testament to his legacy and our future. We are overjoyed at the positive response we’ve received from his fans and our collective customers. Mayer added, “Tommy is a legend and we felt strongly that our first collaboration with an influential figure in the industry should be with someone who is not just an ‘influencer’ but who is and always will be an icon and a champion for cannabis consumers the world over.”


The Tommy Chong Rocket priced at $549, is a limited offering and the presses will be individually hand signed by Tommy as part of a numbered collectible edition available exclusively at


ROSINBOMB continues to be celebrated by experts and leading media outlets. called the Rocket ‘Revolutionary Technology That Creates Perfect THC/CBD Rosin Every time’ and Tech expert website Engadget named the Rocket ‘The Panini Press Of Weed.’


To view the complete line of Rosinbomb presses and accessories please visit


To view all the other exciting and engaging products from Tommy Chong. Please visit


High Tide Inc. (TSXV: HITI) (NASDAQ: HITI), a retail-focused cannabis corporation enhanced by the manufacturing and distribution of consumption accessories, announced that the Company's common shares commenced trading today on the Nasdaq Capital Market under the ticker symbol "HITI". The Company's Nasdaq listing is expected to increase access to investment in High Tide from retail and institutional investors around the world. Furthermore, with access to a much larger capital market, the Company expects to improve liquidity for its Common Shares and, in turn, optimize its cost of capital.


High Tide continues to retain its listing on the TSX Venture Exchange under the symbol "HITI". The ticker used for the Common Shares traded on the OTC Markets quotation system under the current symbol "HITID" has been seamlessly transferred to the new ticker symbol "HITI".


Furthermore, as of today, High Tide is the first major publicly traded cannabis retailer to begin trading on the Nasdaq.


"The listing of the Common Shares on the Nasdaq represents a milestone in the retail cannabis industry and demonstrates the realization of our efforts in turning High Tide into a first-class cannabis retailer," said Raj Grover, President and Chief Executive Officer of High Tide. "High Tide's listing on the Nasdaq gives us access to one of the world's largest capital markets and is in alignment with our long-term goals of enhancing shareholder value by increasing liquidity, optimizing our cost of capital, while furthering High Tide's appeal to international and institutional investors," added Mr. Grover.



Charlotte's Web Holdings, Inc. (TSX: CWEB) (OTCQX: CWBHF), the market leader in hemp CBD wellness products and a Certified B Corporation, today announced the collaboration of its CW Labs division on a preclinical sleep and anxiety study with the University of Colorado-Boulder's REACH (Research and Education Addressing Cannabis and Health) Center. The scientific investigation uses the Company's full spectrum hemp formulations with CBN (cannabinol) and CBD (cannabidiol) and levels of THC below 0.3% to examine the impact on anxiety and sleep quality. The Company is the only hemp CBD brand supporting the University of Colorado REACH Center's milestone study.


There is limited published preclinical or clinical data on phytocannabinoids other than CBD and THC, especially their effect at levels available in commercially sold hemp-derived CBD supplements. There is some anecdotal evidence on the ability of CBN to help with sleep but little substantiated clinical or preclinical evidence to validate these pervasive claims. Long term, it is anticipated that this study will inform future clinical initiatives to better understand how specific ratios of cannabinoids and different delivery formats are effective at supporting improved sleep quality and instilling healthier sleep architecture in humans.


"Charlotte's Web is committed to advancing science on the benefits and safety of CBD and other hemp phytocannabinoids through rigorous scientific investigations such as this sleep and anxiety study," said Tim Orr, Senior Vice President of Charlotte's Web and President of its CW Labs division, which currently has more than a dozen scientific research studies underway.


"We're honored to team up with CU's REACH Center to explore the potential impacts of full-spectrum hemp extract with CBD and CBN on anxiety and sleep quality."

Monika Fleshner, PhD, Professor of Integrative Physiology, and a member of the Center for Neuroscience at the University of Colorado – Boulder is the project lead, and this preclinical study will be conducted in her Stress Physiology Laboratory.  


"There is a great need for properly controlled experimental studies that are designed to test the potential neural and physiological impacts of hemp derived phytocannabinoids. With support from CU REACH and Charlotte's Web, our research will explore both the efficacy and mechanisms of how these substances can affect complex brain-mediated behavior, such as disturbed sleep."


HEXO Corp. (NYSE: HEXO) (TSX: HEXO) , an Ottawa, Ontario-headquartered consumer packaging goods cannabis company, announced a definitive agreement to acquire Redecan, Canada’s largest privately owned licensed producer. HEXO promoted the C$925-million deal as one that will help propel the company to its goal of being the No. 1 licensed producer by market share in Canada.


This acquisition follows two other major deals by HEXO this year, including all-share acquisitions of Zenabis Global Inc. to the tune of $235 million in February and 48North Cannabis Corp. for $50 million earlier this month.


Founded in 2013, HEXO’s $925-million acquisition of Redecan will be its largest deal yet, CEO S├ębastien St-Louis told Cannabis Business Times.


“Well, I’ve never been afraid of price tags,” he said. “What I look for is what’s the fundamental value. [Redecan] had the best growth in the whole industry. So, 169 percent growth year-over-year. They’re the most profitable licensed producer in the industry. And there was a beautiful product overlap. So, from that perspective, it was a hard opportunity to say no to.”


When the transaction closes—expected in the third quarter of 2021—HEXO will hold approximately 17% of the adult-use market share in Canada, according to St-Louis. That percentage, he believes, would provide HEXO a bigger piece of the Canadian market than the Tilray-Aphria combo, which closed a megadeal earlier this month, he said.


In particular, HEXO will hold top market-share positions in Canada’s four largest markets: Alberta, British Columbia, Ontario and Quebec. Those four provinces represent approximately 85% of Canada’s population.


Under the terms of their share purchase agreement, HEXO will pay Redecan shareholders $400 million in cash and $525 million through the issuance of HEXO common shares at an implied price of $7.53 per share.


Redecan has not traditionally had access to the Quebec market, which is where HEXO was founded. Meanwhile, Redecan is far ahead of HEXO in the Ontario market, St-Louis said. From a distribution perspective, there are different retailers and government entities that control those markets.


Also making Redecan attractive to HEXO is its consumer loyalty, St-Louis said.

Redecan is ranked No. 1 in the purchase-to-loyalty conversion metric, with 44% of consumers who purchase Redecan indicating they would repurchase the brand, according to Brightfield Group’s brand health portal for Canada. Redecan is also ranked in the top 10 for converting consumers from awareness to purchase rate, indicating an overall healthy funnel, according to Brightfield data that is fielded quarterly via consumer survey and is normalized on age, gender and province.


“Redecan’s unwavering focus on the consumer, along with lean operating principles and highly efficient automated manufacturing technology, have allowed us to establish a significant presence in the Canadian market,” Redecan co-founder Will Montour said in the press release announcing the acquisition. “We’ve now entered a phase where scale is key, and our complementary consumer bases, brand portfolios and distribution relationships can enhance financial performance.”


“We really didn’t step on each other’s toes,” he said. “The crown jewel from an intellectual property perspective is their ‘Redees.’ They have put together a technology to make marijuana cigarettes that [are] the best in the world. So, bringing that in as an offering that we then as HEXO can bring into the United States is very exciting.”


HEXO and Redecan’s combined strengths should provide a platform for global growth, leveraging HEXO’s international reach, St-Louis said. HEXO already has a foot in the U.S. market with CBD beverages available in Colorado under its Truss Beverages brand.

While the Canadian market has a bright future, HEXO is positioning itself for future expansion in the U.S. and Europe with the intention of becoming one of the top three largest cannabis companies in the world, St-Louis said.


“If we just hold our market share in Canada, Canadian markets should grow two to three times over the next few years,” he said. “So, there’s a lot of upside just in Canada. But we’re quite focused on the United States right now. We think that there’s an opportunity for us to take a lot of our intellectual property and export that to the United States. So, [we want] to take our product line and do things like pre-rolls for the multistate operators and do things like hash for the multistate operators.”


The acquisition is pending approval from the Competition Bureau Canada as well as HEXO shareholder voters, which St-Louis said he foresees as favorable in closing the transaction.


“Joining the HEXO team will leverage our combined strengths and accelerate our growth within Canada and internationally,” Redecan co-founder Pete Montour said in the press release. “We look forward to building a leading global organization together.”


Investor ideas reminds all listeners to read our disclaimers and disclosures on the website and that this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment.


Learn more about our cannabis podcasts at



Investors can trade these stocks and other ideas on our site using our list of top stock trading apps including Robinhood , Acorn, Stash  and others.

To hear more podcasts visit:


The podcasts are also available on iTunes ( Apple Podcasts) ,  Audible , Spotify, Tunein, Stitcher,, iHeartRadio ,  Google Play Music and most audio platforms available.


Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708


About - News that Inspires Big Investing Ideas publishes breaking stock news,  third party stock research , guest posts and original  articles and podcasts in leading stock sectors.  Learn about investing in stocks and get  investor ideas in cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy, gaming and more. Investor Idea’s original branded content includes podcasts and columns : Crypto Corner , Play by Play sports and stock news , Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast ,  Cleantech and Climate Change , Exploring Mining , Betting on Gaming Stocks Podcast and  the AI Eye Podcast.     


Disclaimer/Disclosure: is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. More disclaimer info: Learn more about publishing your news release and our other news services on the newswire and

Global investors must adhere to regulations of each country. Please read privacy policy:


Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.


Learn more about sponsoring this podcast or be a guest and our other branded content opportunities at


Follow us on Twitter

Follow us on Facebook

Follow us on YouTube

Download our Mobile App for iPhone and Android 

Join our Investor Club



800 665 0411



  Get more Cannabis Stock Investor Ideas – news, articles, podcasts and stock directory

No comments:

Post a Comment